Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01462032 · ClinicalTrials.gov registry record · Phase 2
Non-pharmacological Interventions for Preschoolers With Attention Deficit Hyperactivity Disorder (ADHD)
A Phase 2 study, sponsored by Queens College, The City University of New York.
- Completed
- Registry status
- Phase 2
- Development phase
- 52
- Enrollment target
NCT01462032: Completed Phase 2 study, sponsored by Queens College, The City University of New York.
NCT01462032 is a Phase 2 study that has completed, run by Queens College, The City University of New York. The registered enrollment target is 52 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (61% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01462032, a Phase 2 study, has completed, sponsored by Queens College, The City University of New York.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 52 participants
- Enrollment target
Study Summary
This study is designed to evaluate two potential treatments for children with Attention-deficit/Hyperactivity Disorder (ADHD) that do not involve the use of medication. Our goal is to develop new interventions for preschoolers with ADHD that will result in enduring reductions of ADHD symptoms and associated impairments in children, and thus prevent long-term difficulties characteristic of many children with ADHD. Both interventions involve weekly playgroups (of roughly five children) in which children engage in designated activities while parents engage in groups focusing on parent education, support, and their children's activities. It is hypothesized that both interventions will be helpful, but that only one will have lasting effects well beyond the end of active treatment.
Primary Outcome
This is a clinical rating based on data derived from parent and teacher ratings as well as a semi-structured clinical interview with the child's caretaker.
Interventions
- BEHAVIORAL Training Executive, Attention and Motor Skills (TEAMS)
- BEHAVIORAL Parent support and education
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 52 participants |
| Start Date | 2011-04 |
| Est. Completion | 2014-03 |
| Phase | Phase 2 |
What the finished NCT01462032 record still lists
NCT01462032 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 52 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (61% lower).
The record links to 0 conditions, and to 2 interventions - of which Training Executive, Attention and Motor Skills (TEAMS) is the first listed.
NCT01462032 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01462032 about?
NCT01462032 is a clinical study titled "Non-pharmacological Interventions for Preschoolers With Attention Deficit Hyperactivity Disorder (ADHD)". This study is designed to evaluate two potential treatments for children with Attention-deficit/Hyperactivity Disorder (ADHD) that do not involve the use of medication. Our goal is to develop new interventions for preschoolers with ADHD that will result in enduring reductions of ADHD symptoms and as...
What is the current status of trial NCT01462032?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 52 participants. The study started on 2011-04. Estimated completion is 2014-03.
What interventions are being tested in trial NCT01462032?
The interventions under investigation include: Training Executive, Attention and Motor Skills (TEAMS) (BEHAVIORAL), Parent support and education (BEHAVIORAL).
Who is sponsoring clinical trial NCT01462032?
This trial is sponsored by Queens College, The City University of New York, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01462032's enrollment target sits among peer trials
52 1181st of 2000 higher than 811 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02630121 · 52 participants · Phase 4
Effect of Oxymetazoline Hydrochloride in Combination With Fluticasone Propionate on the Apnea Hypopnea Index (AHI) in Subject With Persistent Nasal Congestion and Mild Obstructive Sleep Apnea
- NCT03629171 · 52 participants · Phase 2
Liposome-encapsulated Daunorubicin-Cytarabine and Venetoclax in Treating Participants With Relapsed, Refractory or Untreated Acute Myeloid Leukemia
- NCT04128748 · 52 participants · Phase 1
Liposomal Cytarabine and Daunorubicin (CPX-351) and Quizartinib for the Treatment of Acute Myeloid Leukemia and High Risk Myelodysplastic Syndrome
- NCT04150497 · 52 participants · Phase 1
Phase 1/2 Study of UCART22 in Patients With Relapsed or Refractory CD22+ B-cell Acute Lymphoblastic Leukemia (BALLI-01)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia